review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VIRUSRES.2005.01.009 |
P8608 | Fatcat ID | release_qxmhiqgqszgb7ljo5rjxbrgg5a |
P698 | PubMed publication ID | 15845250 |
P50 | author | Andrzej Górski | Q9152165 |
Wojciech Fortuna | Q73443864 | ||
Beata Weber-Dąbrowska | Q76447322 | ||
Ryszard Międzybrodzki | Q88907329 | ||
P2860 | cites work | Bacteriophage therapy | Q24550616 |
Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature | Q24799893 | ||
New insights into the possible role of bacteriophages in host defense and disease | Q24804005 | ||
RNA interference | Q28131798 | ||
Identification of virus-encoded microRNAs | Q28259309 | ||
Mechanisms of gene silencing by double-stranded RNA | Q28282560 | ||
On the role of RNA amplification in dsRNA-triggered gene silencing | Q29617698 | ||
A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies | Q30717070 | ||
Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium | Q30790381 | ||
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines. | Q30938337 | ||
Uptake and intracellular fate of phage display vectors in mammalian cells. | Q31904008 | ||
Bacteriophage observations and evolution | Q33187340 | ||
Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. | Q33200442 | ||
Bacterial viruses as human vaccines? | Q33205134 | ||
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group | Q33852247 | ||
Cellular receptors for viruses: links to tropism and pathogenesis | Q33919202 | ||
Filamentous phage as vector-mediated antibody delivery to the brain | Q34026070 | ||
Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases | Q34067556 | ||
Role of free radicals in viral pathogenesis and mutation | Q34191797 | ||
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. | Q34327996 | ||
Long-circulating bacteriophage as antibacterial agents | Q34378378 | ||
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection | Q34465399 | ||
The potential role of endogenous bacteriophages in controlling invading pathogens | Q34650343 | ||
Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice | Q35120421 | ||
Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. | Q35182216 | ||
Emerging Trends in Oral Delivery of Peptide and Protein Drugs | Q35570636 | ||
Structure and morphogenesis of bacteriophage T4. | Q35587956 | ||
RNA-dependent RNA polymerases of dsRNA bacteriophages | Q35686319 | ||
Population and evolutionary dynamics of phage therapy | Q35709197 | ||
RNA silencing: a conserved antiviral immunity of plants and animals | Q35739920 | ||
The future of anti-infective products in animal health | Q35752424 | ||
Integrin alpha(v)beta(3) mediates rotavirus cell entry | Q35852198 | ||
Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA. | Q35966987 | ||
Bacteriophage penetration in vertebrates | Q35989564 | ||
Treating cocaine addiction with viruses | Q36672225 | ||
Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus | Q36872657 | ||
Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration | Q36880972 | ||
Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression | Q37309793 | ||
Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens. | Q37492531 | ||
Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. | Q39550459 | ||
The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus | Q39584959 | ||
Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus | Q39682189 | ||
Results of a Five-Year Study of the Curative Effect of Double Stranded Ribonucleic Acid in Viral Dermatoses and Eye Diseases | Q40194264 | ||
The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis | Q40410470 | ||
Adenovirus inhibition by peptidomimetic integrin antagonists | Q40723509 | ||
Lack of Specific Inhibition of Vaccinia Plaque Formation by Bacteriophage Lambda Products | Q40914842 | ||
Oxidative stress during viral infection: a review | Q41188434 | ||
Effect of dsRNA from π6 Bacteriophage on Herpetic Infection in Cell Culture and an Animal Model | Q41663154 | ||
Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage | Q42645443 | ||
Persistent GB virus C infection and survival in HIV-infected men. | Q42983649 | ||
Antibiotic use in relation to the risk of breast cancer | Q43622802 | ||
Human antibody responses to bacteriophage phi X 174: sequential induction of IgM and IgG subclass antibody | Q43770297 | ||
Fate of Bacteriophage Lambda in Non-immune Germ-free Mice | Q43810260 | ||
Bacteriophage collagen | Q44360833 | ||
Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis | Q44869174 | ||
Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle | Q44933279 | ||
Involvement of integrin alphavbeta3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes. | Q45731994 | ||
Anti-vaccinia virus effect of M13 bacteriophage DNA. | Q45768505 | ||
M13 bacteriophage DNA inhibits duck hepatitis B virus during acute infection | Q45778654 | ||
Elution and reconcentration of coliphages in water from positively charged membrane filters with urea-arginine phosphate buffer | Q46760903 | ||
Protection against experimental Newcastle disease in chickens given Brucella bacteriophage | Q47682299 | ||
Arthritogenic properties of double-stranded (viral) RNA. | Q47725563 | ||
Dual function of the extracellular matrix: stimulatory for cell cycle progression of naive T cells and antiapoptotic for tissue-derived memory T cells. | Q51997996 | ||
Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization. | Q52025614 | ||
RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. | Q52592357 | ||
Bacteriophage-mediated nucleic acid immunisation. | Q53644767 | ||
Interferon production by T4 coliphage. | Q53814738 | ||
Bacteriophage therapy. Stalin's forgotten cure. | Q53954501 | ||
Characteristics and diffusion in the rabbit of a phage for Escherichia coli 0103. Attempts to use this phage for therapy | Q54683984 | ||
A member of the immunoglobulin superfamily in bacteriophage T4 | Q55122145 | ||
Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats | Q57350390 | ||
Differential Inhibition by Phagicin of DNA Synthesis in Cells infected with Vaccinia | Q59039334 | ||
The cytogenetic, proliferative and viability effects of four bacteriophages on human lymphocytes | Q67367933 | ||
Incorporation of bacteriophage DNA into the genome of cultured human lymphocytes | Q71065780 | ||
Purification and some possible functions of internal proteins from coliphage T2 | Q72284353 | ||
Oral anti-IgE immunization with epitope-displaying phage | Q73281885 | ||
"My enemy's enemy is my friend." Using phages to fight bacteria | Q76386512 | ||
Fate of bacteriophage particles introduced into mice by various routes | Q78297031 | ||
P433 | issue | 1-2 | |
P304 | page(s) | 1-8 | |
P577 | publication date | 2005-06-01 | |
P1433 | published in | Virus Research | Q15749215 |
P1476 | title | Bacterial viruses against viruses pathogenic for man? | |
P478 | volume | 110 |
Q43468019 | Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes |
Q37929756 | Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens |
Q36652581 | Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria |
Q26822719 | Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection |
Q82674431 | Bacteriophages and transplantation tolerance |
Q52639383 | Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells. |
Q54471348 | Effects of bacteriophages on free radical production and phagocytic functions. |
Q41685260 | Evaluation of nanoparticle tracking analysis for total virus particle determination |
Q38225652 | Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool |
Q61449838 | Perspectives of Phage Therapy in Non-bacterial Infections |
Q53694309 | Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections. |
Q38691927 | Phages and immunomodulation |
Q99608826 | Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection |
Q33828309 | Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention |
Q80267832 | Rapid determination of genomic DNA length for new bacteriophages |
Q38888380 | T4 bacteriophage-mediated inhibition of adsorption and replication of human adenovirus in vitro |
Q46023519 | The evolving role of infectomics in drug discovery. |
Q47269751 | Therapeutic potential of phages in autoimmune liver diseases |